DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Low-Ogestrel (Norgestrel / Ethinyl Estradiol) - Summary

 
 



LOW-OGESTREL SUMMARY

WATSON PHARMA
IN-5186/S
PHYSICIAN LABELING
Low-Ogestrel ®
(Norgestrel and Ethinyl Estradiol Tablets USP,
0.3 mg/0.03 mg)
Rx only

Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.

Low-Ogestrel ® Tablets (norgestrel and ethinyl estradiol tablets USP, 0.3 mg/0.03 mg) provide an oral contraceptive regimen consisting of 21 white tablets followed by 7 peach tablets.

Low-Ogestrel®(norgestrel and ethinyl estradiol tablets USP, 0.3 mg/0.03 mg) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.


See all Low-Ogestrel indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Low-Ogestrel (Norgestrel / Estradiol)

Improved access to female-controlled contraception is needed to help women experiencing intimate partner violence
Source: Sexual Health / STDs News From Medical News Today [2014.09.17]
Access to female-controlled contraceptive methods must be improved in order to help women and girls to counteract any risks to their reproductive health caused by intimate partner violence and...

Research reveals more than half of young women who have abortions were using contraception when they fell pregnant
Source: Abortion News From Medical News Today [2014.04.30]
Reproductive health charity Marie Stopes UK has launched the findings of the first research in the UK into the contraceptive use of women aged 16-24 having one or more abortions.

Males' access to the morning after pill was limited by nearly three-quarters of pharmacies
Source: Sexual Health / STDs News From Medical News Today [2014.09.12]
Male shoppers in search of emergency contraception do not always have an easy time making these purchases and may be turned away at their local pharmacies.

more news >>

Published Studies Related to Low-Ogestrel (Norgestrel / Estradiol)

Laser prostatectomy of lower urinary tract symptoms due to benign prostate enlargement: a critical review of evidence. [2012.01]
PURPOSE OF REVIEW: Different transurethral prostatic laser systems are available. In 2011, new Oxford evidence levels (LoEs) were published with significant changes compared with the former version...

An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. [2012]
and premenstrual syndrome (PMS)... CONCLUSIONS: These data, although not consistent, indicate that continuous LNG/EE

Feasibility of using Short Message Service (SMS) to collect pain outcomes in a low back pain clinical trial. [2011.12.03]
ABSTRACT: Study Design. Observational study nested within a randomized controlled trial.Objective... SMS supplemented with phone interviews, but not SMS alone, is a feasible option to collect simple data within a back pain clinical trial setting.Trial: XXXXXXXXXXXXXXXXXXXXXXXX.

Effect of Core Stability Exercises on Feedforward Activation of Deep Abdominal Muscles in Chronic Low Back Pain: A Randomized Controlled Trial. [2011.12.03]
ABSTRACT: Study Design...

Effect of Motor Control Exercises Versus Graded Activity in Patients With Chronic Nonspecific Low Back Pain: A Randomized Controlled Trial. [2011.12.01]
CONCLUSION:/b>The results of this study suggest that motor control exercises and graded activity have similar effects for patients with chronic nonspecific low back pain.

more studies >>

Clinical Trials Related to Low-Ogestrel (Norgestrel / Estradiol)

Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne� or Placebo. [Recruiting]

Effects of Administration of Fostamatinib on Blood Concentrations of an Oral Contraceptive in Healthy Female Subjects [Recruiting]
A crossover study to assess the effect of repeated doses of fostamatinib on the levels of oral contraceptive (Microgynon® 30) in the blood of healthy female subjects. The study will consist of a screening period of up to 35 days, followed by 2 treatment periods (28 days each) of an oral contraceptive (Microgynon® 30) in the absence and presence of fostamatinib. The study will also evaluate the safety and tolerability of fostamatinib in combination with an oral contraceptive

Observational Trial With Leios/Alesse [Completed]
A prospective, observational study (Anwendungsbeobachtung [AWB]) of the prescribing and administration practices of German gynecologists with Leios® Dragées.

A Study to Investigate the Potential Pharmacokinetic Interaction of Perampanel With Oral Contraceptives in Healthy Female Subjects [Recruiting]

A Study to Evaluate the Pharmacokinetic Drug Interaction Between Multiple Doses of JNJ-31001074 and a Single Dose of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Women [Not yet recruiting]
The main purpose of this research study is to evaluate the effect of multiple doses of an investigational drug known as JNJ-31001074 on the single dose of combination oral contraceptive Ovral-L containing ethinyl estradiol and levonorgestrel in healthy women who cannot bear children. This study will look at the safety, tolerability (how the drug makes you feel) and pharmacokinetics (what your body does to the drug) of either drug alone and in combination in healthy women.

more trials >>


Page last updated: 2014-09-17

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014